Targeted Oncology1h
CAR T-Cells Demonstrate Efficacy, Tolerability in Early-Relapsed DLBCL
During a Case-Based Roundtable® event, Natalie Galanina, MD, discussed data from the ZUMA-7 and TRANSFORM trials in the first ...
AZoLifeSciences on MSN5h
Dysfunctional Memory B Cells Identified as Key Cancer Therapy Target
University of Pittsburgh School of Medicine and UPMC Hillman Cancer Center scientists have discovered a novel subset of ...
Science Daily19h
Scientists identify a new cancer immunotherapy target: Dysfunctional B cells
Scientists have discovered a novel subset of cancer-fighting immune cells that reside outside of their normal neighborhood -- known as the tertiary lymphoid structure -- where they become ...
The Lancet23h
Amyloid-related iatrogenic atrophy of the brain: data transparency is an urgent safety priority
More than 2 years since the original trial data for lecanemab in Alzheimer's disease was published,1 and over 1·5 years since approval by the US Food and Drug Administration, brain volume data have ...